Non categorizzato AstraZeneca’s Q1 core EPS rises 16% to $1.89 Aprile 29, 2022 0 commenti AstraZeneca PLC published on Friday that its total revenue jumped by 56% annually in the first quarter of 2022 to $11.4 billion. The British vaccine maker posted a 16% increase in core earnings per sh… About the author:
Get involved!
Comments